Ellevest Inc’s Atea Pharmaceuticals AVIR Stock Holding History

Ellevest Inc’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13	Closed	–	–	1848
2022 Q3	$0	Sell	13 -16	-55%	-$122	﹤0.01%	1600
2022 Q2	$0	Buy	+29	New	+$198	﹤0.01%	1396
2022 Q1	–	Sell	-9	Closed	–	–	1411
2021 Q4	$0	Buy	9 +2	+29%	+$31	﹤0.01%	1409
2021 Q3	$0	Buy	+7	New	+$194	﹤0.01%	1399

Other funds holding AVIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Ellevest Inc's AVIR Position: Q4 2022 in Review

Ellevest Inc sold out of Atea Pharmaceuticals (AVIR) in Q4 2022, closing a stake of 13 shares.

Ellevest Inc first reported a position in AVIR in Q3 2021 and held it in 4 quarters. The position peaked at $0 in Q3 2022. 131 funds tracked by Wall St. Rank hold AVIR as of Q4 2022.

Ellevest Inc reported no remaining Atea Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Ellevest Inc sold 13 Atea Pharmaceuticals shares in Q4 2022.
Ellevest Inc first reported a position in Atea Pharmaceuticals in Q3 2021 and held it in 4 quarters.
Ellevest Inc's Atea Pharmaceuticals position peaked at $0 in Q3 2022.
131 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.